-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Finch Therapeutics Group, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q2 2024.
- Finch Therapeutics Group, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 1.61M shares, a 0.06% increase year-over-year.
- Finch Therapeutics Group, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.6M shares, a 0.94% increase from 2022.
- Finch Therapeutics Group, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.59M shares, a 95.9% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)